| Dr Ramon T Ungab, MD | |
|
2851 Stage Center Dr, Bartlett, TN 38134-4679 | |
| (901) 388-7711 | |
| (901) 507-2280 |
| Full Name | Dr Ramon T Ungab |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 2851 Stage Center Dr, Bartlett, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053314104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 29547 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Care Of West Tennessee, Inc | Bartlett, TN | Home health agency |
| Baptist Trinity Homecare & Hospice | Memphis, TN | Home health agency |
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Baptist Memorial Hospital | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Care Group, Llc | 0941480131 | 108 |
News Archive
A drug used to treat cancer may also be effective in diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma.
HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.
McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.
In evaluating the bioactive compounds of Illinois blueberry and blackberry wines, University of Illinois scientists have found compounds that inhibit enzymes responsible for carbohydrate absorption and assimilation. And that could mean a tasty way to help people with diabetes decrease their blood sugar.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
› Verified 1 days ago
| Entity Name | Primary Care Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093016651 PECOS PAC ID: 0941480131 Enrollment ID: O20110204000483 |
News Archive
A drug used to treat cancer may also be effective in diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma.
HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.
McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.
In evaluating the bioactive compounds of Illinois blueberry and blackberry wines, University of Illinois scientists have found compounds that inhibit enzymes responsible for carbohydrate absorption and assimilation. And that could mean a tasty way to help people with diabetes decrease their blood sugar.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ramon T Ungab, MD 2851 Stage Center Dr, Bartlett, TN 38134-4679 Ph: (901) 388-7711 | Dr Ramon T Ungab, MD 2851 Stage Center Dr, Bartlett, TN 38134-4679 Ph: (901) 388-7711 |
News Archive
A drug used to treat cancer may also be effective in diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma.
HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.
McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.
In evaluating the bioactive compounds of Illinois blueberry and blackberry wines, University of Illinois scientists have found compounds that inhibit enzymes responsible for carbohydrate absorption and assimilation. And that could mean a tasty way to help people with diabetes decrease their blood sugar.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
› Verified 1 days ago
Shoaib Azam, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3350 N Germantown Rd, Bartlett, TN 38133 Phone: 901-377-2111 Fax: 901-377-5105 | |
Dr. David Dale Sloas, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3350 N Germantown Rd, Bartlett, TN 38133 Phone: 901-377-2111 Fax: 901-377-5105 | |
Dr. Raif Wassef Elsakr, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3350 N Germantown Rd, Bartlett, TN 38133 Phone: 901-377-2111 Fax: 901-377-5105 | |
Dr. Muhammad Saleem, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2686 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-384-9920 | |
David Mark Stern, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 6630 Summer Knoll Cir Ste 101, Bartlett, TN 38134 Phone: 901-746-9438 Fax: 901-746-9331 | |
Wajih Istanbouli, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6570 Summer Oaks Cv, Bartlett, TN 38134 Phone: 901-373-7100 Fax: 901-842-0020 |